Incontinentia Pigmenti BioBank

Incontinentia Pigmentia Rare Genetic Disorder known as IP and all those who it affects are IP Angels.Babies are being misdiagnosed, mothers are losing pregnancies and some infants have gained their wings. This rare disease is unpredictable and the heartache it causes is indescribable.

Skin Rashes and Blisters ~Hair Loss, Thinning and Coarseness ~Misshaped and Missing Teeth ~Blindness and Complete Loss of Eye(s) ~Learning Disabilities ~Fine Motor Delay ~Seizures ~Strokes ~Tumors Under Nails and Ridged Nail Beds ~Bone Deformities ~ Heat Intolerance ~Immune Deficiencies ~ Central Nervous System Defaults and much, much more.

IP can affect every skin cell in the body. IP is the located on the NEMO gene. The NEMO gene is the gateway gene to every birth defect. IP attacks the X a girl is XX a boy XY and with out one healthy X life is not possible.

IP is usually fatal in boys and some girls have also passed because of IP. We do not have many answers medically for this disorder and there is No Cure. Our little ones, teens and IP adults have a 50% chance of passing their IP on and there is no way of knowing how IP will affect each generation. IP is also brought about spontaneously which is when there is NO Family History of this disorder which is then called a spontaneous mutation of IP.

Please Help Us Help IP Families !

An IP BioBank will offer new hope to startups, researchers and patients.
An IP BioBank is a future for IP bringing much neededAnswers and Hope for a CURE!
IP Family Dreams can come true with an IP BioBank

"TheIncontinentia Pigmenti Genetic Biobank(IPGB)
theHuman GeneticsLaboratoryat IGB-ABT CNR inNaples(www.igb.cnr.it/ipgb)isalargestcollection (to date 387 DNAsamples are stored)of DNA andclinical datafrom patients withIncontinentia Pigmenti.The financing will allow us to build all tools to validate the DNA BioBank.
The IPBioBank would be a great opportunity for:
• all patients who, in other parts of the world can be incluse new therapeutic clinical trial project;
• all researchers who, in other parts of the world are working on this type of disease, but do not have access to a sufficient number of cases."

To learn more aboutIP and our foundation (IPIF)please visit us at www.ipif.org